COMMUNIQUÉS West-GlobeNewswire

Shire plc : MYDAYIS(TM) (mixed salts of a single-entity amphetamine product), Shire's New Once-Daily ADHD Treatment, Now Available in the U.S.

28/08/2017 - 13:00

For U.S. Audiences Only MYDAYIS(TM) (mixed salts of a single-entity amphetamine product), Shire's New Once-Daily ADHD Treatment, Now Available in the U.S. Mydayis, which is now available in the U.S., demonstrated [...]

Medtronic Plans for Renal Denervation Pivotal Trial After New Study Shows Significant Blood Pressure Reductions

28/08/2017 - 11:14

Published Simultaneously in The Lancet , the Late-Breaking SPYRAL HTN-OFF MED Study at ESC Successfully Isolates RDN Treatment Effect to Show Compelling Efficacy and Safety of Hypertension Procedure DUBLIN and BARCELONA [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

28/08/2017 - 09:00

FIT Biotech Oy Company release August 28, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - June 30, 2017

28/08/2017 - 08:00

Message from the CEO IBT are currently in the completion stage of the phase II clinical trial (NCT02472769) and are concurrently working with preparations for a subsequent phase III clinical trial. The phase II clinical [...]

Sanofi completes the acquisition of Protein Sciences

28/08/2017 - 07:00

Sanofi completes the acquisition of Protein Sciences - An innovative quadrivalent influenza vaccine will complement Sanofi Pasteur vaccine portfolio - Paris, France - August 28, 2017 - Sanofi announced today that it has [...]

Sanofi finalise l'acquisition de Protein Sciences

28/08/2017 - 07:00

Sanofi finalise l'acquisition de Protein Sciences - Un vaccin antigrippal quadrivalent innovant viendra compléter la gamme de vaccins de Sanofi Pasteur - Paris, France - Le 28 août 2017 - Sanofi annonce aujourd'hui [...]

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

28/08/2017 - 07:00

1. Settlement of vested restricted stock units ("RSUs") Robert Burns, member of the board of directors of Targovax ASA (the "Primary Insider"), has on 25 August 2017 subscribed for 40,984 shares in Targovax ASA at a [...]

Santhera to Publish First Half-Year Report and Corporate Update on September 5, 2017

28/08/2017 - 07:00

Liestal, Switzerland, August 28, 2017 - Santhera Pharmaceuticals (SIX: SANN) will publish its 2017 first half-year report and corporate update on Tuesday, September 5, 2017 at 07:00 CET. An investor conference call with [...]

Novartis Phase III CANTOS study demonstrates that targeting inflammation with ACZ885 reduces cardiovascular risk

27/08/2017 - 11:00

Study showed a significant 15% reduction of major adverse cardiovascular events (MACE) in people with a prior heart attack and inflammatory atherosclerosis who were treated with 150mg of ACZ885, in addition to standard [...]

Novartis announces analysis published in The Lancet showing ACZ885 reduced lung cancer mortality by 77% in the CANTOS study with further studies planned

27/08/2017 - 11:00

Review of blinded, pre-planned oncology safety analyses revealed a 77% reduction in lung cancer mortality and 67% reduction in lung cancer cases in patients treated with 300mg of ACZ885 CANTOS is the first Phase III [...]

Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2018

25/08/2017 - 22:15

DUBLIN - August 25, 2017 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2018 second quarter cash dividend of $0.46 per ordinary share, representing a 7 percent increase over the [...]

Centre for Aging + Brain Health Innovation announces up to $3 million in funding available to support industry innovations in the field of aging and brain health

25/08/2017 - 20:41

TORONTO, Aug. 25, 2017 (GLOBE NEWSWIRE) -- The Centre for Aging + Brain Health Innovation (CABHI) announced today the second round of funding available through its Industry Innovation Partnership Program (I 2 P 2 ). [...]

Victoza® approved in the US as the only type 2 diabetes treatment indicated to reduce the risk of major adverse cardiovascular events

25/08/2017 - 17:26

Bagsværd, Denmark, 25 August 2017 - The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza ® (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events in adults with [...]

Summit Therapeutics plc : Notice of Results

25/08/2017 - 15:30

Summit Therapeutics plc ("Summit" or the "Company") SUMMIT THERAPEUTICS TO REPORT FINANCIAL RESULTS FOR THE SECOND QUARTER AND HALF YEAR ENDED 31 JULY 2017 ON 31 AUGUST 2017 Oxford, UK, · August 2017 - Summit [...]

Minerva Neurosciences Announces European Commission Approval of Amendment of MIN-202 Agreement With Janssen

25/08/2017 - 14:30

Proceeds from amended agreement, combined with finances raised from recent public stock offering and current financial resources, significantly extend Minerva cash runway Combined proceeds are expected to support [...]

Zealand grants new warrants under employee warrant program

25/08/2017 - 13:42

Company announcement - No. 41/2017 Zealand grants new warrants under employee warrant program Copenhagen, August 25, 2017 - Zealand announces the grant of warrants to the Company's President and CEO Britt Meelby Jensen [...]

Exercise of employee share options and restricted stock units in Targovax ASA

25/08/2017 - 13:02

Reference is made to the stock exchange notice of 18 August 2017 regarding increase of the share capital in Targovax ASA (the "Company") relating to exercise of employee options and settlement of restricted stock units [...]

Shire plc : Shire Announces Collaboration with MicroHealth to Address Unique Needs of Hemophilia A and B Patients with Inhibitors

25/08/2017 - 13:00

Shire Announces Collaboration with MicroHealth to Address Unique Needs of Hemophilia A and B Patients with Inhibitors Collaboration leverages digital technology to provide free and secure care monitoring tool Lexington [...]

DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social

25/08/2017 - 11:02

Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]